Literature DB >> 12698043

Update on prostaglandin analogs.

Camille Hylton1, Alan L Robin.   

Abstract

Prostaglandin analogs are a novel class of intraocular-lowering medications used primarily for the treatment of glaucoma. These topical medications reduce intraocular pressure primarily by enhancing uveoscleral outflow. The recent literature has enhanced our understanding of the mechanism of action, efficacy, and safety of these agents and has allowed us to better understand the differences between the three commonly used once-daily medications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12698043     DOI: 10.1097/00055735-200304000-00001

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  16 in total

1.  Effectiveness of the ICare rebound tonometer in patients with overestimated intraocular pressure due to tight orbit syndrome.

Authors:  You Kyung Lee; Y K Lee; Ji Young Lee; J Y Lee; Jung Il Moon; J I Moon; Myoung Hee Park; M H Park
Journal:  Jpn J Ophthalmol       Date:  2014-08-29       Impact factor: 2.447

Review 2.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.

Authors:  Hee Young Choi; Ji Eun Lee; Ji Woong Lee; Hyun Jun Park; Ji Eun Lee; Jae Ho Jung
Journal:  J Ocul Pharmacol Ther       Date:  2011-11-22       Impact factor: 2.671

Review 4.  Management of glaucoma: focus on pharmacological therapy.

Authors:  Robert E Marquis; Jess T Whitson
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use.

Authors:  Thomas V Johnson; Preeya K Gupta; Daljit K Vudathala; Ian A Blair; Angelo P Tanna
Journal:  J Ocul Pharmacol Ther       Date:  2010-11-30       Impact factor: 2.671

6.  Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells.

Authors:  Adrian Smedowski; Jussi J Paterno; Elisa Toropainen; Debasish Sinha; Edward Wylegala; Kai Kaarniranta
Journal:  J Biochem Pharmacol Res       Date:  2014-12-01

7.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30

8.  Serous retinal detachment in the macula related to latanoprost use.

Authors:  Berna Ozkan; V Levent Karabaş; Nurşen Yüksel; Yusuf Cağlar
Journal:  Int Ophthalmol       Date:  2007-09-05       Impact factor: 2.031

9.  Bimatoprost, prostamide activity, and conventional drainage.

Authors:  Zhou Wan; David F Woodward; Clive L Cornell; Hans G Fliri; José L Martos; Simon N Pettit; Jenny W Wang; Alexander B Kharlamb; Larry A Wheeler; Michael E Garst; Kari J Landsverk; Craig S Struble; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

Review 10.  Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension.

Authors:  Greg L Plosker; Susan J Keam
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.